Tharuka, Mohottige D. Neranjan
Courelli, Asimina S.
Chen, Yuan https://orcid.org/0000-0002-1510-182X
Article History
Accepted: 20 February 2025
First Online: 19 March 2025
Competing interests
: Y.C. reports equity ownership and is on the board of directors of Suvalent Therapeutics and CIT Therapeutics outside the submitted work. The other authors declare no competing interests.